Cargando…

Potential Therapeutic Targets and Promising Agents for Combating NAFLD

Nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH), is a growing cause of liver cirrhosis and liver cancer worldwide because of the global increases in obesity, dyslipidemia, hypertension, and type 2 diabetes mellitus. Contrary to the advancements in therapies fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umemura, Atsushi, Kataoka, Seita, Okuda, Keiichiro, Seko, Yuya, Yamaguchi, Kanji, Moriguchi, Michihisa, Okanoue, Takeshi, Itoh, Yoshito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032837/ https://www.ncbi.nlm.nih.gov/pubmed/35453652 http://dx.doi.org/10.3390/biomedicines10040901

Ejemplares similares

Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells
por: Takahashi, Aya, et al.
Publicado: (2021)

Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells
por: Kataoka, Seita, et al.
Publicado: (2021)

Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
por: Okuda, Keiichiro, et al.
Publicado: (2021)

Comparison of portal vein hemodynamics with ultrasound-based elastography for the prediction of liver fibrosis in patients with chronic liver disease
por: Yamaguchi, Kanji, et al.
Publicado: (2023)

Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan
por: Yano, Kota, et al.
Publicado: (2020)

FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
por: Seko, Yuya, et al.
Publicado: (2019)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
por: Seko, Yuya, et al.
Publicado: (2020)

The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease
por: Seko, Yuya, et al.
Publicado: (2021)

Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress
por: Okuda, Keiichiro, et al.
Publicado: (2021)

The additive effect of genetic and metabolic factors in the pathogenesis of nonalcoholic fatty liver disease
por: Seko, Yuya, et al.
Publicado: (2022)

The Association between the Platelet Count and Liver Volume in Compensated Cirrhosis Patients after the Eradication of Hepatitis C virus by Direct-acting Antivirals
por: Seko, Yuya, et al.
Publicado: (2020)

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
por: Seko, Yuya, et al.
Publicado: (2018)

PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat
por: Okishio, Shinya, et al.
Publicado: (2020)

Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice
por: Taketani, Hiroyoshi, et al.
Publicado: (2019)

Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach
por: Soda, Tomohiro, et al.
Publicado: (2022)

Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan
por: Sumida, Yoshio, et al.
Publicado: (2020)

Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan
por: Sakakida, Tomoki, et al.
Publicado: (2023)

Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis
por: Takahashi, Aya, et al.
Publicado: (2020)

Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes
por: Ishiba, Hiroshi, et al.
Publicado: (2020)

Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C
por: Mitsuyoshi, Hironori, et al.
Publicado: (2013)

A Review of Non-operative Treatments for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus
por: Moriguchi, Michihisa, et al.
Publicado: (2017)

Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions
por: Fujii, Hideki, et al.
Publicado: (2017)

Correction to: Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM‑free AIM
por: Shimizu, Tomo, et al.
Publicado: (2022)

Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM-free AIM
por: Shimizu, Tomo, et al.
Publicado: (2022)

Comparison of the effect of light alcohol consumption on Japanese men with and without fatty liver
por: Hara, Tasuku, et al.
Publicado: (2019)

Comparison of the effect of light alcohol consumption on Japanese men with and without fatty liver
por: Hara, Tasuku, et al.
Publicado: (2020)

EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma
por: Yasui, Kohichiroh, et al.
Publicado: (2015)

Nanotechnology in combating biofilm: A smart and promising therapeutic strategy
por: Mohanta, Yugal Kishore, et al.
Publicado: (2023)

An in vivo and in silico evaluation of the hepatoprotective potential of Gynura procumbens: A promising agent for combating hepatotoxicity
por: Tithi, Tanzia Islam, et al.
Publicado: (2023)

Promising role of defensins peptides as therapeutics to combat against viral infection
por: Solanki, Subhash Singh, et al.
Publicado: (2021)

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)

A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
por: Kawaguchi, Takumi, et al.
Publicado: (2018)

Procedure of Direct Hepatic Artery Puncture for the Treatment of Hepatocellular Carcinoma: Two Case Reports
por: Takashima, Hidetaka, et al.
Publicado: (2020)

A Simple Method to Avoid Bile Duct Injury during Percutaneous Radiofrequency Ablation Therapy for Hepatocellular Carcinoma
por: Takashima, Hidetaka, et al.
Publicado: (2020)

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
por: Zhou, Hong, et al.
Publicado: (2020)

Adipose tissue insulin resistance exacerbates liver inflammation and fibrosis in a diet-induced NASH model
por: Hosokawa, Yusei, et al.
Publicado: (2023)

RNA Interference: Promising Approach to Combat Plant Viruses
por: Akbar, Sehrish, et al.
Publicado: (2022)

Computed tomographic pulmonary angiography: Three cases of low-tube-voltage acquisition with a slow injection of contrast medium
por: Urikura, Atsushi, et al.
Publicado: (2022)

The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals
por: Nishioji, Kenichi, et al.
Publicado: (2015)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vj8hfjjnlt5sjnkh0fveipj3aq